Crossmark

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”

Crossref DOI link: https://doi.org/10.1186/s13023-018-0917-0

Published Online: 2018-10-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Grandis, Marina

Geroldi, Alessandro https://orcid.org/0000-0002-2208-9195
Gulli, Rossella

Manganelli, Fiore

Gotta, Fabio

Lamp, Merit

Origone, Paola

Trevisan, Lucia

Gemelli, Chiara

Fabbri, Sabrina

Schenone, Angelo

Tozza, Stefano

Santoro, Lucio

Bellone, Emilia

Mandich, Paola
Funding

Funding for this research was provided by:

Pfizer Inc.
License Information

Text and Data Mining valid from 2018-10-04
More Information

Article History

Received: 20 July 2018

Accepted: 21 September 2018

First Online: 4 October 2018

Ethics approval and consent to participate

: All patients signed an informed consent to genetic study approved by ethical committee of IRCCS Policinico San Martino, Genova, Italy.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.